FLT3 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FLT3 inhibitor, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML [Phase 3]